Access comprehensive financial analyses and make smarter investments - get the Manual of Investments on Amazon!

PRU

Prudential Financial to Sell Businesses in Brazil and Mexico for $4.025 Billion

Prudential Financial said it has agreed to sell Prudential of Brazil and Prudential of Mexico to CNP Assurances for an aggregate cash price of $4.025 billion, marking another step in its exit from emerging markets.

The deal follows Prudential’s previously announced sales of interests in joint ventures in Indonesia, South Africa and Kenya, which closed on October 13. Together, those transactions show the company has been steadily shrinking its emerging-markets footprint.

Prudential said it plans to use the cash proceeds to support capital allocation priorities and fund higher-priority growth areas in retirement, asset management and select protection businesses in the U.S., Japan and selected European markets.

The transaction is expected to close in the second half of 2027, subject to regulatory approvals and other customary closing conditions. No additional deal terms were disclosed.

For CNP Assurances, the acquisition expands its Latin American presence, giving it a stronger position in Brazil and a new entry into Mexico. The buyer said it sees value in the businesses’ life planner network, distribution capabilities and customer relationships. Following these announcements, the company's shares moved -1.93%, and are now trading at a price of $113.67. For the full picture, make sure to review PRUDENTIAL FINANCIAL INC's 8-K report.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS